A landmark formal partnership between the California Institute of Technology and Cedars-Sinai Health Sciences University promises to dissolve the traditional barriers that often separate fundamental scientific research from its practical application in patient care. This strategic alliance,
The decade-long journey for a promising Duchenne muscular dystrophy treatment has reached a devastating conclusion, as PTC Therapeutics has officially withdrawn its application for Translarna from the U.S. market, marking the end of a contentious and ultimately unsuccessful bid for regulatory
As Costa Rican health officials monitor the nation's respiratory illness landscape, data from the Ministry of Health reveals a clear and pressing public health concern: Influenza A has firmly established itself as the most dominant circulating virus, outpacing both rhinovirus and COVID-19. In the
A recent comprehensive investigation by the Centers for Disease Control and Prevention (CDC) has brought a critical public health challenge into sharp focus, identifying extraintestinal invasive Escherichia coli as the foremost cause of sepsis that begins outside of a hospital setting. This
The American biomedical research landscape has emerged into 2026 bearing the deep and complex scars of a profoundly turbulent year, navigating a delicate balance between a renewed sense of financial security and a pervasive anxiety over the integrity of its foundational institutions. Following a
The complex health crises facing modern society, from pandemics to chronic diseases, increasingly demand solutions that transcend the traditional boundaries of scientific disciplines. Recognizing this critical shift, Texas A&M University recently convened the Life Sciences Graduate Recruitment
